These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


368 related items for PubMed ID: 8871925

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Molecular genetic studies of sporadic and familial renal cell carcinoma.
    Gnarra JR, Glenn GM, Latif F, Anglard P, Lerman MI, Zbar B, Linehan WM.
    Urol Clin North Am; 1993 May; 20(2):207-16. PubMed ID: 8098558
    [Abstract] [Full Text] [Related]

  • 5. Polymerase chain reaction-single-strand conformation polymorphism analysis for the VHL gene in chemically induced kidney tumors of rats using intron-derived primers.
    Shiao YH, Diwan BA, Perantoni AO, Calvert RJ, Zbar B, Lerman MI, Rice JM.
    Mol Carcinog; 1997 Aug; 19(4):230-5. PubMed ID: 9290699
    [Abstract] [Full Text] [Related]

  • 6. Genetics of renal-cell carcinoma and evidence for a critical role for von Hippel-Lindau in renal tumorigenesis.
    Gnarra JR, Lerman MI, Zbar B, Linehan WM.
    Semin Oncol; 1995 Feb; 22(1):3-8. PubMed ID: 7855617
    [Abstract] [Full Text] [Related]

  • 7. Screening for renal carcinoma associated mutations in the von Hippel-Lindau tumor suppressor gene by temperature gradient gel electrophoresis.
    Wenzel M, Enczmann J, Uhrberg M, Hernández A, Wiese U, Ackermann R, Schmitz-Draeger B, Ebert T, Wernet P.
    Electrophoresis; 1997 Jan; 18(1):45-51. PubMed ID: 9059819
    [Abstract] [Full Text] [Related]

  • 8. Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas.
    Shuin T, Kondo K, Torigoe S, Kishida T, Kubota Y, Hosaka M, Nagashima Y, Kitamura H, Latif F, Zbar B.
    Cancer Res; 1994 Jun 01; 54(11):2852-5. PubMed ID: 8187067
    [Abstract] [Full Text] [Related]

  • 9. Detection of the von Hippel-Lindau gene deletion in cytologic specimens using microdissection and the polymerase chain reaction.
    Zhuang Z, Roth MJ, Emmert-Buck MR, Lubensky IA, Liotta LA, Solomon D.
    Acta Cytol; 1994 Jun 01; 38(5):671-5. PubMed ID: 8091895
    [Abstract] [Full Text] [Related]

  • 10. A microdissection technique for archival DNA analysis of specific cell populations in lesions < 1 mm in size.
    Zhuang Z, Bertheau P, Emmert-Buck MR, Liotta LA, Gnarra J, Linehan WM, Lubensky IA.
    Am J Pathol; 1995 Mar 01; 146(3):620-5. PubMed ID: 7887444
    [Abstract] [Full Text] [Related]

  • 11. Allelic deletion and mutation of the von Hippel-Lindau (VHL) tumor suppressor gene in pancreatic microcystic adenomas.
    Vortmeyer AO, Lubensky IA, Fogt F, Linehan WM, Khettry U, Zhuang Z.
    Am J Pathol; 1997 Oct 01; 151(4):951-6. PubMed ID: 9327728
    [Abstract] [Full Text] [Related]

  • 12. Establishment of experimental conditions for the rapid detection of mutations in the von Hippel-Lindau gene by parallel temperature gradient gel electrophoresis.
    Hernández A, Meyer A, Enczmann J, Ackermann R, Wernet P.
    Electrophoresis; 1999 Jul 01; 20(10):1958-61. PubMed ID: 10451103
    [Abstract] [Full Text] [Related]

  • 13. Mutation of the VHL gene is associated exclusively with the development of non-papillary renal cell carcinomas.
    Kenck C, Wilhelm M, Bugert P, Staehler G, Kovacs G.
    J Pathol; 1996 Jun 01; 179(2):157-61. PubMed ID: 8758207
    [Abstract] [Full Text] [Related]

  • 14. [Analysis of kidney tumors in trichloroethylene exposed workers by comparative genomic hybridization and DNA sequence analysis].
    Schraml P, Zhaou M, Richter J, Brüning T, Pommer M, Sauter G, Mihatsch MJ, Moch H.
    Verh Dtsch Ges Pathol; 1999 Jun 01; 83():218-24. PubMed ID: 10714214
    [Abstract] [Full Text] [Related]

  • 15. Inactivation of BHD in sporadic renal tumors.
    Khoo SK, Kahnoski K, Sugimura J, Petillo D, Chen J, Shockley K, Ludlow J, Knapp R, Giraud S, Richard S, Nordenskjöld M, Teh BT.
    Cancer Res; 2003 Aug 01; 63(15):4583-7. PubMed ID: 12907635
    [Abstract] [Full Text] [Related]

  • 16. Multifocal bilateral renal cell carcinoma and retinal angiomas in a patient with de novo von Hippel-Lindau disease: identification of a new germline mutation.
    Sessa A, Battini G, Meroni M, Pitingolo F, Righetti M, Ciotti P, Di Maria E, Bellone E, Ajmar F, Mandich P.
    J Nephrol; 2005 Aug 01; 18(2):209-12. PubMed ID: 15931650
    [Abstract] [Full Text] [Related]

  • 17. Somatic mutations of the von Hippel-Lindau tumor suppressor gene in sporadic central nervous system hemangioblastomas.
    Kanno H, Kondo K, Ito S, Yamamoto I, Fujii S, Torigoe S, Sakai N, Hosaka M, Shuin T, Yao M.
    Cancer Res; 1994 Sep 15; 54(18):4845-7. PubMed ID: 8069849
    [Abstract] [Full Text] [Related]

  • 18. Neurofibromatosis type 2 and von Hippel-Lindau disease: from gene cloning to function.
    Kley N, Whaley J, Seizinger BR.
    Glia; 1995 Nov 15; 15(3):297-307. PubMed ID: 8586465
    [Abstract] [Full Text] [Related]

  • 19. Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis.
    Clifford SC, Prowse AH, Affara NA, Buys CH, Maher ER.
    Genes Chromosomes Cancer; 1998 Jul 15; 22(3):200-9. PubMed ID: 9624531
    [Abstract] [Full Text] [Related]

  • 20. Multifocal renal oncocytoma in a patient with Von Hippel-Lindau mutation.
    Fiske J, Patel R, Kau E, Pappas JG, Garcia RA, Taneja SS.
    Urology; 2005 Dec 15; 66(6):1320. PubMed ID: 16360474
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.